A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Clinical trial NCT06132126 · COMPLETED
Trial details
- NCT number
- NCT06132126
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2024-06-28
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.